A 38-year-old man receives a femoral nerve block with 40 mL of 1% lidocaine (400 mg) for knee arthroscopy. Thirty seconds after injection, he develops sudden-onset seizures, followed by loss of consciousness and apnea. His pupils are dilated and unresponsive. The anesthesiologist immediately secures the airway, administers 100% oxygen, and gives a bolus of 20% lipid emulsion 1.5 mL/kg IV. After 2 minutes of seizure control and spontaneous breathing resumption, the patient's cardiac monitor shows a slow, wide-complex rhythm with a rate of 35/min and blood pressure of 65/40 mmHg. What is the next most appropriate intervention?

Explanation

## Cardiovascular Toxicity Phase of LAST with Profound Bradycardia ### Clinical Scenario Analysis The patient has progressed from **CNS toxicity (seizures, apnea)** to **severe cardiovascular toxicity** — profound bradycardia (35/min), hypotension (65/40), and altered mental status. This represents the **late, life-threatening phase** of LAST. **Key Point:** Lipophilic local anesthetics (especially bupivacaine and ropivacaine) cause profound myocardial depression, bradycardia, and conduction block. Lidocaine is less cardiotoxic but still capable of causing severe dysrhythmias at high doses. ### ACLS Modifications in LAST **High-Yield:** Standard ACLS protocols are **MODIFIED** in LAST because: 1. **Epinephrine dosing:** Use ≤1 mcg/kg/min (NOT standard 1 mg boluses) 2. **Vasopressor choice:** Vasopressin and phenylephrine preferred over high-dose epinephrine 3. **Lipid emulsion:** Continued infusion is the cornerstone; CPR may need to be prolonged (>1 hour) 4. **Avoid propofol:** Lipophilic drugs worsen toxicity 5. **Avoid high-dose local anesthetics:** No additional LA agents | Standard ACLS | LAST-Modified ACLS | |---|---| | Epinephrine 1 mg IV q 3–5 min | Epinephrine ≤1 mcg/kg/min IV infusion | | Amiodarone for dysrhythmias | Lipid emulsion bolus + infusion | | Standard CPR duration (20 min) | Prolonged CPR (>1 hour if needed) | | All medications acceptable | Avoid propofol, high-dose LA, vasopressin >0.04 U/min | ### Management of Bradycardia in LAST **Clinical Pearl:** Bradycardia in LAST is **refractory to atropine** because it is caused by direct myocardial depression and conduction block from local anesthetic, NOT vagal hyperactivity. Atropine will NOT restore heart rate. **Correct approach:** 1. **Continue lipid emulsion:** Repeat bolus (1.5 mL/kg) if seizures recur or hemodynamics worsen 2. **Infusion:** 0.25 mL/kg/min for at least 10 minutes after cardiovascular stability 3. **Vasopressor support:** Low-dose epinephrine infusion (≤1 mcg/kg/min) or phenylephrine 4. **Prepare for prolonged CPR:** LAST-induced cardiac arrest may require >1 hour of resuscitation 5. **Consider ECMO/cardiopulmonary bypass:** If conventional resuscitation fails (refractory cardiac arrest) **Mnemonic: "LAST ACLS" = Modified Protocol** - **L**ipid emulsion (bolus + infusion) - **A**void high-dose epinephrine (≤1 mcg/kg/min) - **S**upport with low-dose vasopressors - **T**reat bradycardia with lipid + CPR (NOT atropine) ### Why This Answer is Correct Continuing lipid emulsion infusion with repeat boluses as needed is the **definitive management** of LAST-induced cardiovascular collapse. Prolonged CPR (>1 hour) may be required because lipid emulsion takes time to sequester the drug. Standard ACLS with high-dose epinephrine is contraindicated and may worsen dysrhythmias. [cite:Miller's Anesthesia 8e Ch 16; ASRA Local Anesthetic Systemic Toxicity Guidelines 2016]